Continuous administration of Glu-OC via a subcutaneous osmotic pump lowered blood glucose levels and increased pancreatic β-cell mass, insulin secretion, and insulin sensitivity in mice with high-fat diet-induced obesity [16]. The gene discussed is INS; the disease is obesity disorder.